Venus Concept is a medical technology company developing and commercializing a robotic device, the ARTAS® System, that assists physicians in performing tasks that are a part of a follicular unit extraction surgery, a type of hair restoration procedure. Co.'s product portfolio includes 10 energy-based systems that provide solutions for various applications using Venus Concept's (MP)² technology, as well as the VariPulse, and/or fractional ablative RF, IPL, or laser technologies. Co.'s products include: Venus Legacy; Venus Versa; Venus Viva SR; Venus Freeze (MP)² and Freeze Plus; Venus Velocity; Venus Fiore; Venus Heal; Venus Bliss; Venus Glow; NeoGraft®; and ARTAS® iX. The VERO stock yearly return is shown above.
The yearly return on the VERO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2017 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the VERO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|